Apex Equine Medicine SRL

Apex Equine Medicine reported total assets of 3,590 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).

Company number (CBE) 0771.633.713 · VAT BE0771633713
8210 Zedelgem
active in Veterinary activities (NACE 75000)
operating since 22 Jul 2021 (≈ 5 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apex Equine Medicine shows with a free account.

See the score
Profile
SRL since 2021
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−6,709 €
Equity−897 €
Cash217 €
EBITDA−6,353 €
Total assets3,590 €
Solvency-25.0%
The line marks its sector median: 54.0% (1145 companies).

Change 2022 → 2025: Total assets -89 %

Accounts of the company itself (not consolidated).

The full file covers 5 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apex Equine Medicine's annual accounts

20252024202320222021
Net result−6,709 €
Equity−897 €
Cash217 €
EBITDA−6,353 €
Total assets3,590 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 31 Jul 2026
  • Year ended 31 Dec 2024filed on 30 Jun 2025
  • Year ended 31 Dec 2023filed on 25 Jun 2024
  • Year ended 31 Dec 2022filed on 29 Jun 2023
  • Year ended 31 Dec 2021filed on 17 Aug 2022

Apex Equine Medicine's financial analysis

Management and control of Apex Equine Medicine

1 active director(s) in the register.

Apex Equine Medicine's shareholders and holdings →

Apex Equine Medicine's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0771.633.713
VAT number
BE0771633713
Peppol
Registered · 0208:0771633713 · as of 10 Nov 2026
Legal form
SRL
Incorporated
22 Jul 2021
Registered office
8210 Zedelgem
Latest accounts
2025 · filed on 31 Jul 2026
Activity
Veterinary activities (NACE 75000)

Apex Equine Medicine (SRL) has been based in Zedelgem since 2021, active in: veterinary activities. For 2025, it reports a net loss of 6,709 € and equity of −897 €; its revenue is not published. Its solvency stands at -25.0%, below the median of its sector (54.0%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Apex Equine Medicine

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apex Equine Medicine

What is the revenue of Apex Equine Medicine?

Apex Equine Medicine files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Apex Equine Medicine?

In Belgium, the VAT number is the company number prefixed with BE: BE0771633713 for Apex Equine Medicine, if the company is VAT-registered. Its company number (CBE) is 0771.633.713.

Where is the registered office of Apex Equine Medicine?

According to the CBE register, the registered office of Apex Equine Medicine is in 8210 Zedelgem.

What is the equity of Apex Equine Medicine?

At the close of the 2025 financial year, the equity of Apex Equine Medicine amounts to -897 €, a solvency of -25.0% of total assets.

Who manages Apex Equine Medicine?

The register lists 1 active mandates at Apex Equine Medicine. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apex Equine Medicine

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 18 Sep 2026

No credit card, no commitment.

What each plan unlocks →